ENGN Company Profile and Key Details

enGene Holdings Inc. has 66.99 million shares outstanding. The public float is 32.73 million shares, elevated short interest at 3.19% of float. This equals 1.73 million shares. The short ratio is 1.81 days. Institutional investors hold 107.0% of the float. Insiders own 0.09%.

enGene Holdings Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.36. This means the shares are trading above this model’s fair value.

ENGN has shown mixed momentum, gaining 9.64% over the past week and -2.67% over the past quarter, though year-to-date performance is up 0.78%. Short-term trend indicators are bearishly aligned (SMA20 1.73%, SMA50 6.13%, SMA200 55.16%). The stock’s 14-day RSI is 52.54 (neutral), while the ATR of 0.71 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -18.12% below its high and over 278.49% above its low. Average 10-day trading volume of 734.31 thousand shares is below the 3-month average of 880.47 thousand, indicating normal recent market interest.

enGene Holdings Inc. generated EPS of -$2.29 over the past year. Five-year average earnings growth is -255.92%. Wall Street analysts project EPS growth of 9.16% annually over the next five years. Analyst sentiment is bullish. Analyst rating data shows there are 4 Strong Buy ratings, 5 Buy ratings, 4 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $33.00 to $2.00. The high target offers 1664.71% upside. The low target suggests 6.95% downside. The mean target is $14.19. This offers 658.82% upside. enGene Holdings Inc. earnings surprise history is a mixed track record. The quarter that ended September 08, 2026, missed forecasts by 10.16%. The prior quarter beat by -10.42%. Over the last six quarters, Apple has recorded several small beats. These include 12.12% in September 11, 2025.

enGene Holdings Inc. (NASDAQ:ENGN) closed at $1.85 USD, losing -$0.02 (-0.80%) from the previous close of $1.87. The stock is currently mid-range between its 52-week high and low $1.40 and $12.25. With a market capitalization of about $124.27 million, enGene Holdings Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.27). Key stats such as the average daily volume over the past year has been around 860.40 thousand shares, volume is running light vs its 52-week average. Headquartered in Montreal, QC, enGene Holdings Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Ronald H. W. Cooper, the company employs approximately 82 people and listed since February 01, 2022. Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm.

enGene Holdings Inc. trades at a P/E ratio of -6.61, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 0.56 suggesting the stock is closer to book value. The P/FCF stands at -1.19, also above market averages.

Our AI price prediction model suggests that enGene Holdings Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.07%, with price expected at $1.89 by September 28, 2026, within a range of $1.83 to $1.95 3-Month Outlook: Projected fall of -62.57%, reaching $0.70 by December 11, 2026, with a range of $0.39 to $0.99. 1-Year Outlook: Projected loss of -93.58%, with price at $0.12 by September 14, 2027, within a range of $0.00 to $0.00.

enGene Holdings Inc. (NASDAQ:ENGN) shares are flat 0.78% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows enGene Holdings Inc. trading at a premium to the broader market with a P/E of -6.61. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $18.76, suggesting 903.21% upside. Our AI forecast model points to short-term strength (1.07% over two weeks), a medium-term fall (-62.57% over three months), and a longer-term loss (-93.58% over one year), with expected trading ranges indicating moderate volatility.